One Amicus Therapeutics insider — Perceptive Advisors Llc, 10% Owner — today, purchased 200,000 shares having a market value of approximately $2,779,000, as disclosed in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 100,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 300,000 shares and have averaged 150,000 shares per transaction over this time period.

Insider buy/sell trading at Amicus Therapeutics is higher than the 121 peer company average over the last 90-day period. The Pharmaceuticals peer group saw 83 buy/sell trades during this period for an average of 0.7 transactions per company. The number of shares per buy/sell trade for Amicus Therapeutics insiders was also higher. Within the peer group there were 2,598,449 shares purchased and 4,014,981 shares sold with company insiders having sold 17,067 shares on average.

The data used in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.